Literature DB >> 1322006

Integrins as receptors for extracellular matrix proteins in human cornea.

I Virtanen1, K Tervo, M Korhonen, T Päällysaho, T Tervo.   

Abstract

Extracellular matrix (ECM) proteins form distinct protein families that play a role during tissue maturation, wound healing and maintenance of tissue architecture. Recent studies show that there are tissue type-specific variations in their expression. ECM proteins function by complexing with each other and also by interacting with their cellular receptors, called integrins. Integrins are heterodimeric membrane glycoproteins that are partly cell type-specifically expressed in human tissues. Like other stratified epithelia, corneal epithelium expresses alpha 2 beta 1, alpha 3 beta 1, alpha 6 beta 1, 4, and alpha v beta 1 integrins that mediate attachment to the basement membrane and cell-cell interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322006     DOI: 10.1111/j.1755-3768.1992.tb02163.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Suppl


  4 in total

Review 1.  Basement membranes in the cornea and other organs that commonly develop fibrosis.

Authors:  Paramananda Saikia; Carla S Medeiros; Shanmugapriya Thangavadivel; Steven E Wilson
Journal:  Cell Tissue Res       Date:  2018-10-03       Impact factor: 5.249

2.  Internalization of Staphylococcus aureus by human corneal epithelial cells: role of bacterial fibronectin-binding protein and host cell factors.

Authors:  Bradley D Jett; Michael S Gilmore
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Integrins in human anterior chamber angle.

Authors:  K Tervo; T Päällysaho; I Virtanen; T Tervo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

4.  Identification and characterization of a unique role for EDB fibronectin in phagocytosis.

Authors:  Sabrina Kraft; Verena Klemis; Carla Sens; Thorsten Lenhard; Christian Jacobi; Yvonne Samstag; Guido Wabnitz; Michael Kirschfink; Reinhard Wallich; G Maria Hänsch; Inaam A Nakchbandi
Journal:  J Mol Med (Berl)       Date:  2015-12-05       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.